Axim Biotechnologies Inc (OTCMKTS:AXIM) Enters A Pact To Take Over Sapphire Biotech Inc – FactsAboutCBD

Surna Inc (OTCMKTS:SRNA) has set a new record high in Q3 2019 revenues. It has posted revenues of $5.5 million in Q3, an increase of 66% when compared to the same quarter last year. It is on the backdrop of revenue realization of $3.9 million from two expansion contracts executed with a multi-facility operator in the last quarter.

Chief Executive Officer of Surna, Tony McDonald, said the company is excited to report record profits and revenues consecutively in the second straight quarter. It will focus on profitability and growth going forward to offer rich dividends to the shareholders.

Signs seven control contracts

Surna is pleased to announce the signing of agreements for controls, Sentry IQ sensors, and automation platforms in Q3 2019, with two multi-facility operators for $218,000. The company also entered the other two agreements worth $295,000 for controls with independent cultivators. Surna strengthens its footprint in the automation and technology advancement of the indoor growth facility by improving controls business. The company has signed a total of seven control contracts valued at $687,000 through September 2019.

Custom ducted air handling system

Surna is pleased to deliver a custom ducted air handling system in June 2019. It acts as a substitute for improved and new ductless fan coil units. The ability to deliver high capacity air handling systems expects to bring in new opportunities for the company from multi-facility operators. Surna derived revenues of $2.27 million after it signed sales contracts for ducted air handling systems through September 2019.

Identifies business verticals

Surna expects to complement its climate control business that comprises cultivation management technology, fertigation, lighting, operational improvement analytics, and benches through its already identified business verticals. The company will rope in firms aligned with its strategic direction to enter alliances in co-marketing, reseller, distribution, and product development.

Strategic agreements may become acquisition targets in the future. Surna expects to maintain operating profitability (cash) consistently through the infusion of growth equity, acquisitions, and execution of the growth plan. It plans to get listed on NASDAQ in 2021.

Introduces purpose-built fan coil products

Surna introduced a complete purpose-built fan coil product line in August 2019. They find usage in ductless and ducted operations for large to small indoor cannabis facilities for commercial use.

Source: https://factsaboutcbd.org/axim-biotechnologies-inc-otcmktsaxim-enters-a-pact-to-take-over-sapphire-biotech-inc-3419


Recommended


What is CBD Oil

CBD Benefits

cbd oil effects